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Introduction
Cisplatin, or cis-diamminedichloridoplatinum(II) (Fig. 1) , is a remarkable small molecule that has made a large impact in the world of medicinal inorganic chemistry. Indeed, cisplatin has been used in the treatment of metastatic ovarian and testicular cancers for over thirty years, working primarily through a mechanism involving cross-linking DNA and inhibiting transcription. 1, 2 Cisplatin is believed to enter the cell where it is purported to undergo aquation with loss of one or both of the chloride ligands. The 
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A recent paper by Gust and co-workers demonstrated that salicylaldimine complexes of platinum also displayed significant in vitro antitumour activity against MCF-7 human breast cancer cells. 6 Variation of the salicylaldimine groups greatly altered the growth inhibitory effects for these compounds and improved activities were observed with electron withdrawing groups. Encouraged by these results, and our own interest in developing non-traditional platinum anticancer complexes, we have also reported that bis(salicylaldiminato)platinum(II) complexes had appreciable cytotoxic activity against three human glioma cell lines. 7 Unfortunately, these complexes suffered from poor solubility, limiting any additional studies. 
General synthesis of mono Schiff base platinum complexes
Under an atmosphere of dinitrogen, a hexane solution of n-BuLi (1.0 mL of a 1.6 M solution, 1.6 mmol) was added to a toluene (5 mL) solution of the appropriate Schiff base 
Stability testing of platinum complexes in the presence of water
In an NMR tube, compound 5 was dissolved in CDCl3 (1 mL) and D2O (3 drops) was added. The mixture was analyzed by 1 H NMR spectroscopy after 1, 2, 4, and 24 h. D r a f t
X-ray crystallography
Crystals of 4 were grown from a saturated toluene solution stored at 5 o C. Crystals of 7
were grown by slow evaporation of a hexane solution at RT under an inert atmosphere.
Single crystals were coated with Paratone-N oil, mounted using a polyimide MicroMount, and frozen in the cold nitrogen stream of the goniometer. Hemispheres of data were collected on a Bruker AXS P4/SMART 1000 diffractometer using ω and φ scans with a scan width of 0.3 o and 10 s exposure times. The detector distance was 5 cm. The crystal of 4 was twinned and the orientation matrixes for two components were determined (CELL_NOW) 13 and integration of the data resulted in 94% completeness.
The data were reduced (SAINT) 14 and corrected for absorption (TWINABS). 15 The structure was solved by direct methods and refined by full-matrix least squares on to equal values and atoms in close proximities were constrained to the same thermal parameters. For 4 and 7, all non-hydrogen atoms were refined using anisotropic D r a f t
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displacement parameters and hydrogen atoms were included in calculated positions and refined using a riding model.
Cell cultures and biological testing
The complexes. [18] [19] [20] [21] [22] [23] [24] [25] [26] The FT-IR spectra show the expected decrease in the frequency of the C=N bond due to complexation, which is observed as the νC=N stretch shifts from ca.
1632 cm -1 for the free ligands to ca. 1614 cm -1 for the platinum compounds. 12 As well, the absence of the νOH shift in the metal complexes, observed at ca. 2860 cm -1 for the free Schiff bases, further confirms coordination of these bidentate ligands. As seen by multinuclear NMR spectroscopy, the cyclooctene ligand remains coordinated to the platinum centre as the 1 H NMR data show a broad multiplet at ca. 
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Complexes 4 and 7 have also been characterized by single crystal X-ray diffraction studies, the molecular structure of both square planar complexes are shown in Figure 2 and relevant crystal data are given in Table 1 . In both structures, the nitrogen is trans to the alkene group of cyclooctene. The imine carbon-nitrogen bond lengths are 1.313 (11) Å (4) typical for those observed in other three coordinate boron compounds. 27 The boron atom in 7 is observed as a broad resonance at 30 ppm by 11 B NMR spectroscopy, indicative of a three-coordinate boron environment in solution.
While compounds 1-6 are insoluble, yet stable, in water, the cyclooctene group has been shown to drastically improve solubilities in common organic solvents such as CHCl3, CH2Cl2, and THF over the corresponding bis Schiff base analogues. 7 Exploiting lipophilic groups to improve the delivery of platinum complexes in cancer treatment has been recently studied. [28] [29] [30] In this study, compounds 1-3 have been prepared from long-chain amines to enhance lipophilicity. We have also employed electronically diverse aromatic amines for complexes 4-7 in order to determine whether electron-donating (5) or electron-withdrawing groups (6,7) have any effect upon the anticancer activities of the resultant platinum compounds. Platinum complexes containing only one chloride ligand D r a f t
14 have recently shown cytotoxic efficacy towards human ovarian carcinoma cells. 31, 32 Unfortunately, while boron-containing compounds are being examined for their potential bioactivites, 33 complex 7 decomposes readily in air via B-C bond cleavage and loss of the boron group to give 4 and other unidentified products, precluding biological testing of this complex.
Scheme 1. Synthesis of complexes 1-7.
(a) (b) 
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In order to evaluate the potential of complexes 1-6 as a source of anticancer agents, we first assessed the biological effects of the compounds on an aggressive breast cancer cell line (MB231), using cisplatin as a control. 34 
Conclusions
In summary, we have prepared a small family of organometallic platinum complexes containing a chloride, cis-cyclooctene, and a Schiff base ligand. Fine-tuning the steric and electronic properties of the complexes was done by variation of the starting amine used to make the Schiff base ligands with salicylaldehyde. Three aliphatic amines with varying chain lengths and four aromatic amines with electron-donating and electronwithdrawing properties were chosen as representative examples. Although the complex containing an electron-withdrawing boron group (7) proved not to be stable in air, the remaining six complexes were examined for potential anticancer activities. Interestingly, complex 3, which contained the longest aliphatic chain studied (an octyl group), was the most promising for inducing apoptosis in the malignant MB231 breast cancer cell line.
Conversely, complexes 4-6, which contained the aromatic groups, were the most active against renal cell carcinoma (RCC) cell lines. Unfortunately, these complexes also showed significant cytotoxicity towards normal cell lines. Although these results are 
